Serum Institute of India

SII CEO Adar Poonawalla has issued a statement to address the controversy regarding the cost of Covishield.

The previous low price was a part of SII's commitment to GOI and some other countries for sharing the risk of production. After the current 'under contract' 110 million doses are delivered, SII will sell to GOI at Rs 400 per dose, same as states.

Serum Institute had offered GOI a discount for 1st 100 million doses, it will not be making huge profits from states as alleged

After relentless attack on Ambani and Adani, Rahul Gandhi now targets Adar Poonawalla, calls him Modi's friend

Serum Institute of India to provide COVISHIELD at Rs 400 to state governments, Rs 600 to private hospitals

Yesterday, the government had approved advance payments to SII and Bharat Biotech worth Rs 3000 crores and 1567.50 crores respectively.

Adar Poonawalla appealed to Joe Biden to lift the embargo on the export of raw materials so that manufacturing of vaccines can be ramped up

In an interview with India Today, Adar Poonawalla said the COVID-19 vaccine manufacturers are finding it difficult to ramp up production because the US, Europe are holding back critical raw material exports.

Subramanian Swamy insinuated that Covishield is responsible for at least 70 deaths that allegedly occurred after the vaccination drive

American Scientist Dr Hortez said India's COVID-19 vaccine rollout has 'rescued the world' by providing a large supply of low-cost vaccines.